Who owns the INSTARELEASE trademark?

The INSTARELEASE trademark is owned by INSTAMED PHARMACEUTICALS, INC..

What class is the INSTARELEASE trademark registered in?

The INSTARELEASE trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for INSTARELEASE?

The USPTO serial number for INSTARELEASE is 99239273.

What is the registration number for INSTARELEASE?

INSTARELEASE is registered under USPTO registration number 8372437.

INS

USPTO Trademark Record

REGISTERED

INSTARELEASE

SN 99239273·Reg 8372437·Filed Jun 17, 2025

Owner INSTAMED PHARMACEUTICALS, INC.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

INSTARELEASE (Serial No. 99239273), Registration No. 8372437, is a registered US trademark filed on Jun 17, 2025 by INSTAMED PHARMACEUTICALS, INC.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: July 28, 2032

Mark Intelligence

INSTARELEASE (Reg. #8372437) is a registered US trademark that has been protecting its owner, INSTAMED PHARMACEUTICALS, INC., since 2025. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jun 17, 2025

SERIAL

99239273

REG#

8372437

REGISTERED

Jul 28, 2026

Owner

Applicant

INSTAMED PHARMACEUTICALS, INC.

Entity

Corporation

State

Address

12411 S. 265 W. UNIT C, Draper, UT, 84020

Country

Attorney

NameDavid W. Osborne

Law firm

David W. Osborne Thorpe North & Western, LLP

Docket

5016-012.TM

Address

8180 S. 700 E. Suite 350, Sandy, UT 84070, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateJun 17, 2025

Serial Number99239273

Registration No.8372437

Registration DateJul 28, 2026

Status DateJul 28, 2026

Published for OppositionNov 04, 2025

Mark TypeStandard characters

Attorney Docket5016-012.TM

Status DescriptionLive and registered

Filing Signals

FILED

2025

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Apr 30, 2025

First use in commerce: Apr 30, 2025

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

22 events

REGISTERED-PRINCIPAL REGISTER

Jul 28, 2026

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jul 28, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jul 08, 2026

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jul 08, 2026

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

STATEMENT OF USE PROCESSING COMPLETE

Jul 07, 2026

STATEMENT OF USE PROCESSING COMPLETE

TEAS STATEMENT OF USE RECEIVED

Apr 15, 2026

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Apr 15, 2026

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Dec 30, 2025

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Nov 04, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Nov 04, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Oct 29, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Oct 03, 2025

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Sep 12, 2025

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Sep 12, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Sep 12, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Aug 14, 2025

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Aug 14, 2025

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Aug 14, 2025

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Aug 13, 2025

ASSIGNED TO EXAMINER

APPLICATION FILING RECEIPT MAILED

Jun 17, 2025

APPLICATION FILING RECEIPT MAILED

NEW APPLICATION ENTERED

Jun 17, 2025

NEW APPLICATION ENTERED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jun 17, 2025

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

INSTARELEASE

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by INSTAMED PHARMACEUTICALS, INC.

Other Marks by David W. Osborne

Resources

Company